Conflict of interest
Lin-Chi, NMS
ONCOLOGY, NMS, EMD
Anastasios Stathis: Consultancy services (institution) to Bayer, Eli Lilly; Advisory (institution): Roche, Janssen; institutional research funding: MSD, AstraZeneca, Roche, AbbVie, Pfizer, Bayer, Novartis, ADC Therapeutics, MEI Therapeutics, Loxo Oncology, Philogen.Anthony W. Tolcher: ABBVIE, Inc, Aclaris Therapeutics, AGENUS, Inc., ASANA BIOSCIENCES, ASCENTAGE, Axlmmune, Bayer, Blu Print Oncology, Daiichi Sankyo, Inc., GILDE HEALTHCARE PARTNERS, HBM PARTNERS, IDEA Pharma, Immuneering, Immunomet Therapeutics, Inc., Impact Therapeutics US, Inc., Karma Oncology B.V., Kirilys Therapeutics, Inc., Lengo Therapeutics, Inc., Link Immunotherapeutics, Mekanistic Therapeutics, Menarini Ricerche, Mersana, NANOBIOTIX, NervianoMedical Sciences S.r.I. (NMS), Nurix Therapeutics, Ocellaris Pharma, Inc. & Eli Lilly, Partner Therapeutics, Pfizer Inc., Qualigen Therapeutics, PIERRE FABRE, Roche, RYVU THERAPEUTICS, Seattle Genetics, SK Life Science, SOTIO Biotechnology Co., Spirea Limited Inc., Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, Transcenta Therapeutics Inc., Trillium Therapeutics Inc., Verastem Oncology, VRISE Therapeutics, Inc., Zentails, ADAGENE, Inc., ARO BIOTHERAPEUTICS, BIOINVENT, Boehringer Ingelheim International GmbH, Deka Biosciences, Eleven Bio, ELUCIDA, EMD SERONO/ MERCK KGaA, Hiber Cell, Inc., Ikena Oncology, IMMUNOME, Janssen Global Services, LLC, NBE THERAPEUTICS, Pelican, JAZZ, Pieris Pharma, PYXIS Oncology, Senti Biosciences, Vincerx, ZielBio, Inc., Zymeworks Biopharmaceuticals Inc., MIRATI, Roche.Judy S.Wang: Consultant fees from BioNTech, Stemline/Menarini, Janssen, Kanaph. Speakers’ Bureau fees from AstraZeneca and Eisai. Research Funding paid to institution only from: Takeda, Medimmune, Genentech, AstraZeneca, El Lilly, Lycera, Pfizer, Checkpoint, Agenus, Jacobio, Evelo, Merck, Jounce, Boehringer Ingelheim, Janssen, Vedanta, H3 Biomedicine, BioNTech, Phoenix Molecular Designs, Bicycle, Qilu Puget Sound, Xencor, Sanofi, Klus, Treadwell, IGM, PureTech, Erasca, Bayer, BioTheryX, Biosplice, NGM, Cullinan, Astellas, BeiGene, Pinoyr, Taiho, Mirati, Hutchinson MediPharma, Stemline, GSK, TopAlliance, Revolution, Relay, StingThera.Daniel J. Renouf: Consultancy services: Bayer, Roche, Elevation; Research funding: Roche.Lin-Chi Chen, Tomoko Freshwater, Andrea L. Webber, Tapan Nayak: Employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and stockholders in Merck & Co., Inc., Rahway, NJ, USA.Leah H. Suttner: Employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.Lillian L. Siu: Advisory Role/Consultation (self): Amgen, Arvinas, AstraZeneca, Coherus, Hoopika, InteRNA, Janpix, Marengo, Medicenna, Navire, Oncorus, Relay, Roche, Seattle Genetics, Tessa, Voronoi. Research Support (institution): Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, EMD Serono/Merck KGaA, GlaxoSmithKline, Intensity Therapeutics, Merck, Novartis, Pfizer, Roche/Genentech, Shattucks, Symphogen. Leadership Role (spouse): Treadwell Therapeutics.